Q3 2019 Holdings
Filed 2019-11-14 | 22 holdings | $3.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abbvie Inc(ABBV) | COM | 00287Y109 | $3.8M | 50,000 | 98.7% |
| Spdr S&P 500 ETF TR(SPY)Put | TR UNIT | 78462F103 | $14.8K | 50,000 | 0.4% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $4.4K | 70,000 | 0.1% |
| Glaxosmithkline PLC | SPONSORED ADR | 37733W105 | $4.3K | 100,000 | 0.1% |
| Proshares TR IICall | VIX SH TRM FUTRS | 74347W171 | $3.9K | 200,000 | 0.1% |
| Gilead Sciences Inc(GILD)Call | COM | 375558103 | $3.2K | 50,000 | 0.1% |
| CVS Health Corp(CVS) | COM | 126650100 | $3.2K | 50,000 | 0.1% |
| Walgreens Boots Alliance Inc(WBA) | COM | 931427108 | $2.8K | 50,000 | 0.1% |
| Tyme Technologies Inc | COM | 90238J103 | $2.6K | 2,175,000 | 0.1% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $1.7K | 250,000 | 0.0% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $1.7K | 35,000 | 0.0% |
| Amerisourcebergen Corp(COR) | COM | 03073E105 | $1.6K | 20,000 | 0.0% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $1.4K | 10,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $1.0K | 200,000 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $1.0K | 1,400,000 | 0.0% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $983 | 250,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $760 | 250,000 | 0.0% |
| Greenlane Hldgs Inc | CL A | 395330103 | $678 | 200,000 | 0.0% |
| Antares Pharma Inc(ATRSEUR) | COM | 036642106 | $669 | 200,000 | 0.0% |
| Antares Pharma Inc(ATRSEUR)Call | COM | 036642106 | $669 | 200,000 | 0.0% |
| Foamix Pharmaceuticals LTDCall | SHS | M46135105 | $152 | 50,000 | 0.0% |
| Tyme Technologies IncCall | COM | 90238J103 | $119 | 100,000 | 0.0% |